Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Real-Time Analyzers is a private analytical instrumentation and diagnostics company that designs, manufactures, and markets Raman, surface-enhanced Raman spectroscopy (SERS), and near-infrared spectroscopy systems for chemical, biochemical, and materials analysis. Its product portfolio includes portable and process Raman analyzers, fuel property analyzers, SERS consumables, and rapid assay systems. In healthcare- and life-science-adjacent applications, the company has marketed a Listeria assay kit and developed a saliva-based COVID-19 antigen test, alongside broader biochemical and pathogen detection capabilities. The business appears to be primarily a tools-and-devices company rather than a therapeutic drug developer, serving laboratory, field, industrial, defense, food-safety, and select diagnostic use cases. Its offerings are built around rugged spectroscopy hardware and associated consumables for real-time identification and characterization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Real-Time Analyzers.